Four (4) each Genomic Sequencing Systems

The Food and Drug Administration (FDA) is acquiring four Illumina MiSeq i100 Plus desktop genomic sequencing systems, or brand-name equivalent technology, for the Human Foods Program (HFP). This procurement replaces aging hardware used for food safety surveillance and regulatory compliance. The agency requires these systems to detect and characterize foodborne pathogens while maintaining compatibility with existing methods, flow cells, and reagents. The scope includes the sequencing units, the Illumina DRAGEN Bio-IT Platform, software licenses, and manufacturer-supported components. The contract features a 12-month base warranty and four option years for preventative maintenance. Delivery and performance will occur at FDA locations in Maryland, Illinois, and Alabama. Evaluation follows the Lowest Price Technically Acceptable (LPTA) methodology based on 14 salient characteristics defined in the Statement of Work. Responses are due by June 26, 2026. This procurement replaces aging hardware to ensure continued food safety surveillance and pathogen characterization. The FDA is purchasing four Illumina MiSeq i100 Plus desktop genomic sequencing systems, or equivalent, to support the Human Foods Program (HFP). This equipment replaces older units to maintain continuity in food safety surveillance and pathogen characterization. The scope includes hardware delivery, on-site installation, system validation, and training for FDA staff at multiple laboratories.